{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ban-Lan-Gen granule", "GLP-1", "colitis", "gut microbiota", "short-chain fatty acids"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35250294", "DateRevised": {"Year": "2022", "Month": "05", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.2147/JIR.S352863"], "Journal": {"ISSN": "1178-7031", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2022"}}, "Title": "Journal of inflammation research", "ISOAbbreviation": "J Inflamm Res"}, "ArticleTitle": "Ban-Lan-Gen Granule Alleviates Dextran Sulfate Sodium-Induced Chronic Relapsing Colitis in Mice via Regulating Gut Microbiota and Restoring Gut SCFA Derived-GLP-1 Production.", "Pagination": {"StartPage": "1457", "EndPage": "1470", "MedlinePgn": "1457-1470"}, "Abstract": {"AbstractText": ["GLP-1 based therapy represents a new treatment option for inflammatory bowel disease. Ban-Lan-Gen (BLG) granule, a known anti-viral TCM formulation, exhibits potential anti-inflammatory activities in treating various kinds of inflammation. However, its anti-inflammatory effect on colitis and the underlying mechanisms remain unknown.", "Dextran sulfate sodium (DSS)-induced chronic relapsing colitis in mice was established. The disease activity index, histological sign of damage, and levels of proinflammatory cytokines were performed to assess the protective effects of BLG. Serum GLP-1 level and colonic Gcg, GPR41 and GRP43 expression, the community compositions of gut microbiota, the levels of SCFAs in the feces and GLP-1 release from primary murine colon epithelial cells were performed to characterize the effects of BLG on gut microbiota and gut SCFA derived-GLP-1 production.", "BLG treatment significantly alleviated body weight loss, DAI, colon shortening, colon tissue damage, and pro-inflammatory cytokine levels of TNF-\u03b1, IL-1\u03b2 and IL-6 in the colon tissues. Moreover, BLG treatment could observably restore colonic Gcg, GPR41 and GRP43 expression and serum GLP-1 level of colitic mice, as well as correct the alteration of gut microbiota in colitic mice by increasing the abundances of SCFA-producing bacteria, eg, <i>Akkermansia</i> and <i>Prevotellaceae_UCG-001</i>, and decreasing the abundances of bacteria, eg, <i>Eubacterium_xylanophilum_group, Ruminococcaceae_UCG-014, Intestinimonas</i>, and <i>Oscillibacter</i>. Furthermore, BLG treatment could markedly increase the levels of SCFAs in feces of colitic mice. In parallel, ex vivo assay also showed that and the extract of feces from BLG-treatment mice could greatly stimulate the secretion of GLP-1 from primary murine colon epithelial cells.", "These findings suggest that the anti-colitis effects of BLG are achieved at least partly by regulating gut microbiota and restoring gut SCFA derived-GLP-1 production, and BLG has the potential to be developed as a promising agent for the treatment of chronic relapsing colitis."], "CopyrightInformation": "\u00a9 2022 Peng et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, People's Republic of China."}, {"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, People's Republic of China."}], "LastName": "Peng", "ForeName": "Jiao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Gastroenterology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China."}], "LastName": "Li", "ForeName": "Xi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM, Ministry of Education, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, People's Republic of China."}], "LastName": "Zheng", "ForeName": "Lin", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China."}], "LastName": "Duan", "ForeName": "Lifang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, People's Republic of China."}], "LastName": "Gao", "ForeName": "Zhengxian", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China."}], "LastName": "Hu", "ForeName": "Die", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China."}], "LastName": "Li", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China."}], "LastName": "Li", "ForeName": "Xiaofeng", "Initials": "X"}, {"Identifier": ["0000-0002-4333-9106"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, People's Republic of China."}], "LastName": "Shen", "ForeName": "Xiangchun", "Initials": "X"}, {"Identifier": ["0000-0001-5951-4426"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, People's Republic of China."}], "LastName": "Xiao", "ForeName": "Haitao", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "J Inflamm Res", "NlmUniqueID": "101512684", "ISSNLinking": "1178-7031"}, "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tang B, Zhu J, Zhang B, et al. Therapeutic potential of triptolide as an anti-inflammatory agent in dextran sulfate sodium-induced murine experimental colitis. Front Immunol. 2020;11:592084. doi:10.3389/fimmu.2020.592084", "ArticleIdList": ["10.3389/fimmu.2020.592084", "PMC7680904", "33240279"]}, {"Citation": "Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720\u2013727. doi:10.1038/nrgastro.2015.150", "ArticleIdList": ["10.1038/nrgastro.2015.150", "26323879"]}, {"Citation": "Peng J, Zheng TT, Li X, et al. Plant-Derived Alkaloids: the Promising Disease-Modifying Agents for Inflammatory Bowel Disease. Front Pharmacol. 2019;10:351. doi:10.3389/fphar.2019.00351", "ArticleIdList": ["10.3389/fphar.2019.00351", "PMC6473079", "31031622"]}, {"Citation": "Xiao HT, Peng J, Wen B, et al. Indigo Naturalis Suppresses Colonic Oxidative Stress and Th1/Th17 Responses of DSS-Induced Colitis in Mice. Oxid Med Cell Longev. 2019;2019:9480945. doi:10.1155/2019/9480945", "ArticleIdList": ["10.1155/2019/9480945", "PMC6815543", "31737179"]}, {"Citation": "Chen M, Ding Y, Tong Z. Efficacy and Safety of Sophora flavescens (Kushen) Based Traditional Chinese Medicine in the Treatment of Ulcerative Colitis: clinical Evidence and Potential Mechanisms. Front Pharmacol. 2020;11:603476. doi:10.3389/fphar.2020.603476", "ArticleIdList": ["10.3389/fphar.2020.603476", "PMC7758483", "33362558"]}, {"Citation": "Cao F, Liu J, Sha BX, Pan HF. Natural Products: experimental Efficient Agents for Inflammatory Bowel Disease Therapy. Curr Pharm Des. 2019;25:4893\u20134913. doi:10.2174/1381612825666191216154224", "ArticleIdList": ["10.2174/1381612825666191216154224", "31840596"]}, {"Citation": "Zhang C, Jiang M, Lu A. Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis. Clin Rev Allergy Immunol. 2013;44:274\u2013283. doi:10.1007/s12016-012-8328-9", "ArticleIdList": ["10.1007/s12016-012-8328-9", "22669756"]}, {"Citation": "Li ZT, Li L, Chen TT, et al. Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial. Trials. 2015;16:126. doi:10.1186/s13063-015-0645-x", "ArticleIdList": ["10.1186/s13063-015-0645-x", "PMC4383212", "25873046"]}, {"Citation": "Li Z, Li L, Zhou H, et al. Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro. Molecules. 2017;1:22.", "ArticleIdList": ["PMC6155848", "28085062"]}, {"Citation": "Ruan D, Liu W, Shi Y, et al. Protective Effects of Aqueous Extract of Radix Isatidis on Lipopolysaccharide-Induced Sepsis in C57BL/6J Mice. J Med Food. 2020;23:79\u201389. doi:10.1089/jmf.2019.4476", "ArticleIdList": ["10.1089/jmf.2019.4476", "31765267"]}, {"Citation": "Wang X, Xie Y, Hu X, et al. Qualitative and quantitative analysis of glucosinolates and nucleosides in Radix Isatidis by HPLC and liquid chromatography tandem mass spectrometry. Acta Pharm Sin B. 2013;3:337\u2013344. doi:10.1016/j.apsb.2013.08.002", "ArticleIdList": ["10.1016/j.apsb.2013.08.002", "PMC7104192", "32288995"]}, {"Citation": "Shi Y, Zheng C, Li J, Yang L, Wang Z, Wang R. Separation and Quantification of Four Main Chiral Glucosinolates in Radix Isatidis and Its Granules Using High-Performance Liquid Chromatography/Diode Array Detector Coupled with Circular Dichroism Detection. Molecules. 2018;23:746.", "ArticleIdList": ["PMC6100438", "29844266"]}, {"Citation": "Sugimoto S, Naganuma M, Kanai T. Indole compounds may be promising medicines for ulcerative colitis. J Gastroenterol. 2016;51:853\u2013861. doi:10.1007/s00535-016-1220-2", "ArticleIdList": ["10.1007/s00535-016-1220-2", "27160749"]}, {"Citation": "Tokuyasu N, Shomori K, Amano K, et al. Indirubin, a Constituent of the Chinese Herbal Medicine Qing-Dai, Attenuates Dextran Sulfate Sodium-induced Murine Colitis. Yonago Acta Med. 2018;61:128\u2013136. doi:10.33160/yam.2018.06.005", "ArticleIdList": ["10.33160/yam.2018.06.005", "PMC6015798", "29946219"]}, {"Citation": "Gao W, Guo Y, Wang C, et al. Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells. Acta Histochem. 2016;118:606\u2013614. doi:10.1016/j.acthis.2016.06.004", "ArticleIdList": ["10.1016/j.acthis.2016.06.004", "27396532"]}, {"Citation": "Ercan G, Yigitturk G, Erbas O. Therapeutic effect of adenosine on experimentally induced acute ulcerative colitis model in rats. Acta Cir Bras. 2020;34:e201901204. doi:10.1590/s0102-865020190120000004", "ArticleIdList": ["10.1590/s0102-865020190120000004", "PMC7025795", "32074166"]}, {"Citation": "Jeengar MK, Thummuri D, Magnusson M, Naidu VGM, Uppugunduri S. Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Sci Rep. 2017;7:3924. doi:10.1038/s41598-017-04041-9", "ArticleIdList": ["10.1038/s41598-017-04041-9", "PMC5478663", "28634361"]}, {"Citation": "Li YH, Xiao HT, Hu DD, et al. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses. Pharmacol Res. 2016;110:227\u2013239. doi:10.1016/j.phrs.2016.02.010", "ArticleIdList": ["10.1016/j.phrs.2016.02.010", "26969793"]}, {"Citation": "Xiao HT, Lin CY, Ho DH, et al. Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis. J Nat Prod. 2013;76:2120\u20132125. doi:10.1021/np4006772", "ArticleIdList": ["10.1021/np4006772", "24200352"]}, {"Citation": "Psichas A, Sleeth ML, Murphy KG, et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes. 2015;39:424\u2013429. doi:10.1038/ijo.2014.153", "ArticleIdList": ["10.1038/ijo.2014.153", "PMC4356745", "25109781"]}, {"Citation": "He J, He Y, Pan D, Cao J, Sun Y, Zeng X. Associations of Gut Microbiota With Heat Stress-Induced Changes of Growth, Fat Deposition, Intestinal Morphology, and Antioxidant Capacity in Ducks. Front Microbiol. 2019;10:903. doi:10.3389/fmicb.2019.00903", "ArticleIdList": ["10.3389/fmicb.2019.00903", "PMC6498187", "31105682"]}, {"Citation": "Li Y, Wang S, Sun Y, et al. Apple polysaccharide protects ICR mice against colitis associated colorectal cancer through the regulation of microbial dysbiosis. Carbohydr Polym. 2020;230:115726. doi:10.1016/j.carbpol.2019.115726", "ArticleIdList": ["10.1016/j.carbpol.2019.115726", "31887919"]}, {"Citation": "Tao JH, Duan JA, Jiang S, Guo JM, Qian YY, Qian DW. Simultaneous determination of six short-chain fatty acids in colonic contents of colitis mice after oral administration of polysaccharides from Chrysanthemum morifolium Ramat by gas chromatography with flame ionization detector. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1029-1030:88\u201394. doi:10.1016/j.jchromb.2016.07.002", "ArticleIdList": ["10.1016/j.jchromb.2016.07.002", "27428450"]}, {"Citation": "Franzosa EA, Sirota-Madi A, Avila-Pacheco J, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4:293\u2013305. doi:10.1038/s41564-018-0306-4", "ArticleIdList": ["10.1038/s41564-018-0306-4", "PMC6342642", "30531976"]}, {"Citation": "Zhu L, Xu LZ, Zhao S, Shen ZF, Shen H, Zhan LB. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis. Appl Microbiol Biotechnol. 2020;104:5449\u20135460. doi:10.1007/s00253-020-10527-w", "ArticleIdList": ["10.1007/s00253-020-10527-w", "32322944"]}, {"Citation": "Zhang Z, Wu X, Cao S, et al. Chlorogenic Acid Ameliorates Experimental Colitis by Promoting Growth of Akkermansia in Mice. Nutrients. 2017;9:98.", "ArticleIdList": ["PMC5537792", "28661454"]}, {"Citation": "Shen F, Zheng RD, Sun XQ, Ding WJ, Wang XY, Fan JG. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2017;16:375\u2013381. doi:10.1016/S1499-3872(17)60019-5", "ArticleIdList": ["10.1016/S1499-3872(17)60019-5", "28823367"]}, {"Citation": "Foreman RE, George AL, Reimann F, Gribble FM, Kay RG. Peptidomics: a Review of Clinical Applications and Methodologies. J Proteome Res. 2021;20:3782\u20133797. doi:10.1021/acs.jproteome.1c00295", "ArticleIdList": ["10.1021/acs.jproteome.1c00295", "34270237"]}, {"Citation": "Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364\u2013371. doi:10.2337/db11-1019", "ArticleIdList": ["10.2337/db11-1019", "PMC3266401", "22190648"]}, {"Citation": "Ducastel S, Touche V, Trabelsi MS, et al. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids. Sci Rep. 2020;10:174. doi:10.1038/s41598-019-56743-x", "ArticleIdList": ["10.1038/s41598-019-56743-x", "PMC6957696", "31932631"]}, {"Citation": "Kou FS, Shi L, Li JX, et al. Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: a multi-center, randomized, double-blind, controlled trial. Medicine. 2020;99:e21903. doi:10.1097/MD.0000000000021903", "ArticleIdList": ["10.1097/MD.0000000000021903", "PMC7458163", "32871923"]}, {"Citation": "Xiao HT, Zhong L, Tsang SW, Lin ZS, Bian ZX. Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings. Am J Chin Med. 2015;43:1\u201323. doi:10.1142/S0192415X15500019", "ArticleIdList": ["10.1142/S0192415X15500019", "25579759"]}, {"Citation": "Liang X, Huang Y, Pan X, et al. Erucic acid from Isatis indigotica Fort. suppresses influenza A virus replication and inflammation in vitro and in vivo through modulation of NF-kappaB and p38 MAPK pathway. J Pharm Anal. 2020;10:130\u2013146. doi:10.1016/j.jpha.2019.09.005", "ArticleIdList": ["10.1016/j.jpha.2019.09.005", "PMC7192973", "32373385"]}, {"Citation": "Naganuma M, Sugimoto S, Fukuda T, et al. Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study. J Gastroenterol. 2020;55:169\u2013180. doi:10.1007/s00535-019-01625-2", "ArticleIdList": ["10.1007/s00535-019-01625-2", "31529220"]}, {"Citation": "Chiba M, Nakane K, Tsuji T, et al. Relapse Prevention by Plant-Based Diet Incorporated into Induction Therapy for Ulcerative Colitis: a Single-Group Trial. Perm J. 2019;2:23.", "ArticleIdList": ["PMC6499111", "31050638"]}, {"Citation": "Yue SJ, Wang WX, Yu JG, et al. Gut microbiota modulation with traditional Chinese medicine: a system biology-driven approach. Pharmacol Res. 2019;148:104453. doi:10.1016/j.phrs.2019.104453", "ArticleIdList": ["10.1016/j.phrs.2019.104453", "31541688"]}, {"Citation": "Feng W, Ao H, Peng C, Yan D. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 2019;142:176\u2013191. doi:10.1016/j.phrs.2019.02.024", "ArticleIdList": ["10.1016/j.phrs.2019.02.024", "30818043"]}, {"Citation": "Derrien M, Van Baarlen P, Hooiveld G, Norin E, Muller M, de Vos WM. Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol. 2011;2:166. doi:10.3389/fmicb.2011.00166", "ArticleIdList": ["10.3389/fmicb.2011.00166", "PMC3153965", "21904534"]}, {"Citation": "Bian X, Wu W, Yang L, et al. Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Front Microbiol. 2019;10:2259. doi:10.3389/fmicb.2019.02259", "ArticleIdList": ["10.3389/fmicb.2019.02259", "PMC6779789", "31632373"]}, {"Citation": "Hu L, Jin L, Xia D, et al. Nitrate ameliorates dextran sodium sulfate-induced colitis by regulating the homeostasis of the intestinal microbiota. Free Radic Biol Med. 2020;152:609\u2013621. doi:10.1016/j.freeradbiomed.2019.12.002", "ArticleIdList": ["10.1016/j.freeradbiomed.2019.12.002", "31811920"]}, {"Citation": "Zou J, Shen Y, Chen M, et al. Lizhong decoction ameliorates ulcerative colitis in mice via modulating gut microbiota and its metabolites. Appl Microbiol Biotechnol. 2020;104:5999\u20136012. doi:10.1007/s00253-020-10665-1", "ArticleIdList": ["10.1007/s00253-020-10665-1", "32418127"]}, {"Citation": "Katano Y, Fujinami S, Kawakoshi A, et al. Complete genome sequence of Oscillibacter valericigenes Sjm18-20(T) (=NBRC 101213(T)). Stand Genomic Sci. 2012;6:406\u2013414. doi:10.4056/sigs.2826118", "ArticleIdList": ["10.4056/sigs.2826118", "PMC3558957", "23408234"]}, {"Citation": "Wu M, Li P, An Y, et al. Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol Res. 2019;150:104489. doi:10.1016/j.phrs.2019.104489", "ArticleIdList": ["10.1016/j.phrs.2019.104489", "31689519"]}, {"Citation": "Wang CS, Li WB, Wang HY, et al. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. World J Gastroenterol. 2018;24:4254\u20134262. doi:10.3748/wjg.v24.i37.4254", "ArticleIdList": ["10.3748/wjg.v24.i37.4254", "PMC6175759", "30310258"]}, {"Citation": "Parada Venegas D, De la Fuente MK, Landskron G, et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol. 2019;10:277. doi:10.3389/fimmu.2019.00277", "ArticleIdList": ["10.3389/fimmu.2019.00277", "PMC6421268", "30915065"]}, {"Citation": "Luu M, Visekruna A. Short-chain fatty acids: bacterial messengers modulating the immunometabolism of T cells. Eur J Immunol. 2019;49:842\u2013848. doi:10.1002/eji.201848009", "ArticleIdList": ["10.1002/eji.201848009", "31054154"]}, {"Citation": "Zatorski H, Salaga M, Fichna J. Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:1321\u20131330. doi:10.1007/s00210-019-01698-z", "ArticleIdList": ["10.1007/s00210-019-01698-z", "31359088"]}, {"Citation": "Anbazhagan AN, Thaqi M, Priyamvada S, et al. GLP-1 nanomedicine alleviates gut inflammation. Nanomedicine. 2017;13:659\u2013665. doi:10.1016/j.nano.2016.08.004", "ArticleIdList": ["10.1016/j.nano.2016.08.004", "PMC5501083", "27553076"]}, {"Citation": "Villumsen M, Schelde AB, Jimenez-Solem E, Jess T, Allin KH. GLP-1 based therapies and disease course of inflammatory bowel disease. EClinicalMedicine. 2021;37:100979. doi:10.1016/j.eclinm.2021.100979", "ArticleIdList": ["10.1016/j.eclinm.2021.100979", "PMC8343256", "34386751"]}, {"Citation": "Ning MM, Yang WJ, Guan WB, Gu YP, Feng Y, Leng Y. Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2. Acta Pharmacol Sin. 2020;41:1446\u20131456. doi:10.1038/s41401-020-0413-7", "ArticleIdList": ["10.1038/s41401-020-0413-7", "PMC7656800", "32398684"]}, {"Citation": "Kato S, Sato T, Fujita H, Kawatani M, Yamada Y. Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms. Sci Rep. 2021;11:9167. doi:10.1038/s41598-021-88612-x", "ArticleIdList": ["10.1038/s41598-021-88612-x", "PMC8080802", "33911125"]}, {"Citation": "Larraufie P, Martin-Gallausiaux C, Lapaque N, et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Sci Rep. 2018;8:74. doi:10.1038/s41598-017-18259-0", "ArticleIdList": ["10.1038/s41598-017-18259-0", "PMC5758799", "29311617"]}, {"Citation": "Yang Q. Study on acute toxicity of the compound Radix Spray. Sci Edu Article Coll. 2013;3:92\u201393."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "7"}, {"Year": "2022", "Month": "2", "Day": "18"}, {"Year": "2022", "Month": "3", "Day": "7", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "3", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "8", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["35250294", "PMC8896204", "10.2147/JIR.S352863", "352863"]}}], "PubmedBookArticle": []}